Huge Interest In EMA's Public Hearing On Side-Effects Of Quinolones, Fluoroquinolones
Executive Summary
The European Medicines Agency has chosen 23 speakers from 55 requests made by people interested in sharing their experiences with the use of these widely-prescribed antibiotics.
You may also be interested in...
EMA Acts On Patient Concerns Over Fluoroquinolone Antibiotics
Three months after hearing testimonies of patients who suffered severe side-effects from the use of quinolones and fluoroquinolones, the European Medicines Agency has recommended that some of these medicines should be removed from the market and the labeling of others should be changed to restrict their use.
EU Patients Decry Medical ‘Ignorance’ About Side-Effects Of Quinolones & Fluoroquinolones
At the European Medicines Agency's second ever public hearing on the safety of marketed medicines, patients gave an emotional account of how they battled with 'ignorance' within the EU medical community about the severely debilitating and potentially permanent side-effects of some broad-spectrum antibiotics.
EMA Sets Date For Quinolone, Fluoroquinolone Public Hearing
People interested in participating in the European Medicines Agency’s second ever public hearing and sharing their experiences about the risks associated with quinolone and fluoroquinolone antibiotics must register to do so no later than April 30.